A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2004
11/10/2004	EP1474108A2 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
11/10/2004	EP1474093A2 Granzyme b inhibitors
11/10/2004	EP1473990A2 Cardiac-specific 11 beta hydroxysteroid dehydrogenase type 2 transgenic mice
11/10/2004	EP1370560B1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists
11/10/2004	EP1267897B1 Treatment of congestive heart failure by pretreated autologous blood
11/10/2004	EP1261605B1 Benzoxazole derivatives as tnf and pde iv inhibitors
11/10/2004	EP1248833A4 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition
11/10/2004	EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/10/2004	EP1144389B1 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoicacid]calcium salt
11/10/2004	EP1131050B8 Galenic formulations fast disintegrating in the mouth and method for preparing same
11/10/2004	EP1102567B1 Cardiac disease treatment device
11/10/2004	CN1545522A Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander
11/10/2004	CN1545515A 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative
11/10/2004	CN1545512A Rapamycin dialdehydes
11/10/2004	CN1545511A Rapamycin 29-enols
11/10/2004	CN1545509A Piperidine derivatives useful as modulators of chemokine receptor activity
11/10/2004	CN1545505A Polymorph salt of a pyridazinone derivative for the treatment of arrythmia
11/10/2004	CN1545415A Bone anabolic compounds and methods of use
11/10/2004	CN1545413A Stabilized formulations of 6-hydroxy-3-(4-[piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene and salts thereof
11/10/2004	CN1544429A Bee glue flavone extract preparation method, pharmaceutical preparation and its new medical uses
11/10/2004	CN1544418A N-aryl substituted-1H-pyrrole derivative possessing cardiovascular activity
11/10/2004	CN1544086A Application of apolipoprotein A-I in the preparing process for medicine capable of resisting endotoxin and inhibiting cytokine release
11/10/2004	CN1544064A Freeze-dried 'Shengmai' powder for injection and its preparing process
11/10/2004	CN1544045A Traditional Chinese medicinal plaster for treating angiitis and its preparing process
11/10/2004	CN1544043A Bunao Yishen Runchang Capsule for replenishing brain and kidney and moistening intestines
11/10/2004	CN1544042A Liuwei Dihuang dripping pills and its preparation
11/10/2004	CN1544037A Health care medicine capable of strengthening heart and kidney function and immunologic function
11/10/2004	CN1544022A Chinese traditional medicine particle for treating pulmonary heart disease
11/10/2004	CN1544021A Chinese traditional medicine preparation Qishenmai for treating coronary heart disease and angina pectoris and its preparing process
11/10/2004	CN1544017A Chinese patent medicine for treating angiitis
11/10/2004	CN1543999A Chinese traditional medicine preparation for treating cardiac and cerebral vascular diseases and its preparation process
11/10/2004	CN1543992A Apoplexy treating Chinese traditional medicine and its preparation
11/10/2004	CN1543980A Mohailin dripping pills and its preparation
11/10/2004	CN1543977A Medicine for treating cerebrovascular and cardiovascular diseases and preparation process thereof
11/10/2004	CN1543976A Astragaloside injection preparation and its preparing process
11/10/2004	CN1543975A Powder injection of hawthorn leaf flavonid salt and its preparation
11/10/2004	CN1543974A Notoginsen triterpenes liposome and prepartion thereof
11/10/2004	CN1543973A Highly effective sustained release breviscapine compositions and its granule capsule
11/10/2004	CN1543971A Oral disintegrating tablet and its preparation of compound red sage root
11/10/2004	CN1543969A Application of Japanese raspberry saponin in the treatment of cerebral ischemia disease
11/10/2004	CN1543955A Freeze-dried dipyrimadole preparation for injection and prepartion thereof
11/10/2004	CN1543948A Amlodipine and nifedipine medicinal composition
11/10/2004	CN1543942A Haw leaf general flavone soft capsule and preparation thereof
11/10/2004	CN1543939A Ferulaic acid sodium transfusion and prescription and preparation thereof
11/10/2004	CN1543938A Atenolol guttate pill and method for preparing the same
11/10/2004	CN1543933A Curcumin injection and method for preparing the same
11/10/2004	CN1543859A Use of ligustilide for prevention and treatment of atherosclerosis
11/10/2004	CN1174993C VEGI, an inhibitor for angiogenesis and tumor growth
11/10/2004	CN1174986C Tricyclic benzodiazepines as vasopressin receptor antagonists
11/10/2004	CN1174984C Carbamoyl tetrahydropyridine derivatives
11/10/2004	CN1174981C Imidazole [1,2-A] pyridine and pyrazole [2,3-a] pyridine derivatives
11/10/2004	CN1174975C Benzopyrans compound and their use as therapeutic agent
11/10/2004	CN1174956C Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/10/2004	CN1174764C Externally applied medicinal wine for curing Buerger disease
11/10/2004	CN1174756C Process for preparing medicine for treating cerebral thrombus and its sequelae
11/10/2004	CN1174744C Thermal formed solid releasing-controlled medicinal composition
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815458 Nervous system disorders
11/09/2004	US6815457 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin e-2,4-dione, maleic acid salt in polymorphic form
11/09/2004	US6815455 Benzimidazole compounds and drugs containing the same
11/09/2004	US6815451 1,2,3,4-Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815420 Methods of using chemokine beta-6
11/09/2004	US6814985 Herbal compositions and uses for the treatment of allergic reactions
11/09/2004	US6814964 Supramolecules containing binding and therapeutic molecules bound to hybridized nucleic acids
11/09/2004	CA2126195C Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094638A1 Vasculitis antigen and method of diagnosing vasculitis
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094446A1 Remedies for diseases caused by strengthened vascular smooth muscle using 14-membered ring macrolide compounds
11/04/2004	WO2004094428A1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo`2, 3d! pyrimidine hydrogen mesylate and its polymorphic forms
11/04/2004	WO2004094425A1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004094422A1 Substituted pyrroline kinase inhibitors
11/04/2004	WO2004094407A1 Five-membered heterocyclic derivative
11/04/2004	WO2004094404A1 4-imidazolin-2-one compounds
11/04/2004	WO2004094396A2 Dihydrothiazine prodrugs of thiazolium agents
11/04/2004	WO2004093995A2 Use of antioxidants to treat bone loss disorders
11/04/2004	WO2004093913A1 Treatment of hypertension
11/04/2004	WO2004093910A1 REMEDY FOR CEREBRAL NEURODEGENERATIVE DISEASES USING PPARδ AGONIST
11/04/2004	WO2004093852A2 Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004093797A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
11/04/2004	WO2004093781A2 Podophyllotoxin derivatives as igf-1r inhibitors
11/04/2004	WO2004069254A3 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders
11/04/2004	WO2004069232A3 Egfr tyrosine kinase inhibitor for treating cardiovascular dysfunction
11/04/2004	WO2004067506A3 Substituted heterocyclic compounds
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004056353A3 Device and method for delivering mmp inhibitors
11/04/2004	WO2003102135A3 Control sequences of the human corin gene
11/04/2004	WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/04/2004	WO2003089903A3 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
11/04/2004	WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds
11/04/2004	WO2003078431A8 Aza-bicyclic n-biarylamides with affinity for the alpha-7 nicotinic acetylcholine receptor
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	WO2003000183A3 Method of treating atherosclerosis and other inflammatory diseases

1 ... 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 ... 1595